RKER-012, a novel modified ActRIIB ligand trap, attenuated right ventricular cardiomyopathy in a preclinical model of pulmonary arterial hypertension.
30 August 2024 (08:00 - 17:30)
Organised by: 

About the speakers

Keros Therapeutics, Lexington (United States of America)

(United States of America)
5 More presentations in this session
Professor M. Holinstat (Ann Arbor, US)
Access the full session
The Event
ESC Congress 2024
30 August - 2 September 2024
You may be interested in
Congress Presentation
Congress Presentation



